Cargando…
CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich’s Ataxia
Friedreich’s ataxia (FRDA) is an autosomal recessive neurodegenerative disorder caused by expansion of GAA repeats in intron 1 of the frataxin (FXN) gene, leading to significant decreased expression of frataxin, a mitochondrial iron-binding protein. We previously reported that syngeneic hematopoieti...
Autores principales: | Rocca, Celine J., Rainaldi, Joseph N., Sharma, Jay, Shi, Yanmeng, Haquang, Joseph H., Luebeck, Jens, Mali, Prashant, Cherqui, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240056/ https://www.ncbi.nlm.nih.gov/pubmed/32462051 http://dx.doi.org/10.1016/j.omtm.2020.04.018 |
Ejemplares similares
-
Advantages and Limitations of Gene Therapy and Gene Editing for Friedreich’s Ataxia
por: Sivakumar, Anusha, et al.
Publicado: (2022) -
Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893) -
The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
por: Koeppen, Arnulf H., et al.
Publicado: (2015) -
The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905) -
Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)